Scriptaid, a Novel Histone Deacetylase Inhibitor, Protects Against Traumatic Brain Injury via Modulation of PTEN and AKT Pathway: Scriptaid Protects Against TBI via AKT

Traumatic brain injury (TBI) is a leading cause of motor and cognitive deficits in young adults for which there is no effective therapy. The present study characterizes the protective effect of a new histone deacetylase inhibitor, Scriptaid (Sigma-Aldrich Corporation, St. Louis, MO), against injury...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang, Guohua, Jiang, Xiaoyan, Pu, Hongjian, Zhang, Wenting, An, Chengrui, Hu, Xiaoming, Liou, Anthony Kian-Fong, Leak, Rehana K., Gao, Yanqin, Chen, Jun
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3557358/
https://ncbi.nlm.nih.gov/pubmed/23132328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-012-0157-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares